Tags

Type your tag names separated by a space and hit enter

Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests.
Psychooncology. 2008 Jul; 17(7):668-75.P

Abstract

OBJECTIVE

Adjustment disorders (ADs) and major depressive disorder (MDD) are often the most prevalent psychiatric disorders among cancer patients. This study's objective was to determine the overall performance of Hospital Anxiety and Depression Scale (HADS) as a screening instrument in identifying cases of psychiatric morbidity such as ADs and MDD.

METHODS

Two hundred and four consecutive patients completed a questionnaire including a demographic and clinical data form, HADS, and were examined with the Structured Clinical Interview for DSM-IV (SCID). The screening performance of HADS was investigated by calculating the area under the receiver operating characteristics curves (AUC), rates of specificity, and sensitivity.

RESULTS

For MDD; the AUC was 0.77 on the HADS total, the AUC was 0.79 on the HADS depression subscale, and was 0.72 on the anxiety subscale. For ADs; the results were 0.74, 0.74, and 0.70 respectively. Findings indicated that a HADS total cut-off score of > or =17 to be optimal in identifying cases of MDD. This cut-off score offered a sensitivity of 0.70 and a specificity of 0.80. Findings suggested that a HADS total cut-off score of 10 was the optimal combination of sensitivity (0.84) and specificity (0.55) for ADs. When compared with SCID, the percentage of cases identified by HADS was 28% for MDD and 22% for ADs.

CONCLUSIONS

Compared with SCID, HADS was found to have acceptable levels of sensitivity and specificity in detecting psychiatric morbidity especially for MDD and HADS can be recommended with reservations as a screening tool for breast cancer patients.

Authors+Show Affiliations

Ankara Oncology Training and Research Hospital, Psychiatry Clinic, Ankara, Turkey. elvanozalp@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

17992701

Citation

Ozalp, Elvan, et al. "Psychiatric Morbidity and Its Screening in Turkish Women With Breast Cancer: a Comparison Between the HADS and SCID Tests." Psycho-oncology, vol. 17, no. 7, 2008, pp. 668-75.
Ozalp E, Soygür H, Cankurtaran E, et al. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology. 2008;17(7):668-75.
Ozalp, E., Soygür, H., Cankurtaran, E., Turhan, L., Akbiyik, D., & Geyik, P. (2008). Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psycho-oncology, 17(7), 668-75.
Ozalp E, et al. Psychiatric Morbidity and Its Screening in Turkish Women With Breast Cancer: a Comparison Between the HADS and SCID Tests. Psychooncology. 2008;17(7):668-75. PubMed PMID: 17992701.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. AU - Ozalp,Elvan, AU - Soygür,Haldun, AU - Cankurtaran,Eylem, AU - Turhan,Levent, AU - Akbiyik,Derya, AU - Geyik,Pinar, PY - 2007/11/10/pubmed PY - 2008/10/18/medline PY - 2007/11/10/entrez SP - 668 EP - 75 JF - Psycho-oncology JO - Psychooncology VL - 17 IS - 7 N2 - OBJECTIVE: Adjustment disorders (ADs) and major depressive disorder (MDD) are often the most prevalent psychiatric disorders among cancer patients. This study's objective was to determine the overall performance of Hospital Anxiety and Depression Scale (HADS) as a screening instrument in identifying cases of psychiatric morbidity such as ADs and MDD. METHODS: Two hundred and four consecutive patients completed a questionnaire including a demographic and clinical data form, HADS, and were examined with the Structured Clinical Interview for DSM-IV (SCID). The screening performance of HADS was investigated by calculating the area under the receiver operating characteristics curves (AUC), rates of specificity, and sensitivity. RESULTS: For MDD; the AUC was 0.77 on the HADS total, the AUC was 0.79 on the HADS depression subscale, and was 0.72 on the anxiety subscale. For ADs; the results were 0.74, 0.74, and 0.70 respectively. Findings indicated that a HADS total cut-off score of > or =17 to be optimal in identifying cases of MDD. This cut-off score offered a sensitivity of 0.70 and a specificity of 0.80. Findings suggested that a HADS total cut-off score of 10 was the optimal combination of sensitivity (0.84) and specificity (0.55) for ADs. When compared with SCID, the percentage of cases identified by HADS was 28% for MDD and 22% for ADs. CONCLUSIONS: Compared with SCID, HADS was found to have acceptable levels of sensitivity and specificity in detecting psychiatric morbidity especially for MDD and HADS can be recommended with reservations as a screening tool for breast cancer patients. SN - 1099-1611 UR - https://www.unboundmedicine.com/medline/citation/17992701/Psychiatric_morbidity_and_its_screening_in_Turkish_women_with_breast_cancer:_a_comparison_between_the_HADS_and_SCID_tests_ L2 - https://doi.org/10.1002/pon.1286 DB - PRIME DP - Unbound Medicine ER -